# OnCo record aramis (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/aramis/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "aramis", "NCT02200614" ;
  schema:name "ARAMIS"@en ;
  schema:description "ARAMIS showed that darolutamide, an androgen receptor blocker that barely enters the brain, delayed metastases and lengthened life in men whose prostate cancer was rising on hormone therapy but not yet visible on scans, with side effects close to placebo."@en ;
  schema:url <https://onco.cc/trials/aramis/> ;
  schema:dateModified "2026-09-17"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT02200614> ;
  onco:status "positive" ;
  onco:tag "subtype-trials" ;
  onco:phase "3" ;
  onco:cancers <https://onco.cc/cancers/prostate-nmcrpc/>, <https://onco.cc/cancers/prostate/> ;
  onco:drugs <https://onco.cc/drugs/darolutamide/> ;
  onco:companies <https://onco.cc/companies/bayer/> ;
  onco:people <https://onco.cc/people/karim-fizazi/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-aramis-nejm-2019/> .